IFF Names Two to Prestigious Master Perfumer Designation
International Flavors & Fragrances Inc. (NYSE:IFF) (Euronext Paris: IFF), a leading innovator of sensory experiences that move the world, has named Francisco Marano and Stephen Nicoll as Master Perfumers. The Company’s designation recognizes perfumers who have demonstrated consistent and outstanding levels of creativity and craftsmanship in the art of perfumery, and exceptional leadership in and measurable impact on the industry. The addition of Messrs. Marano and Nicoll, both of whom work in Consumer Fragrances, bring the total number at this prestigious level at IFF to four, including Carlos Benaim (2013) and Dominique Ropion (2018). The title was established at the Company in 2013.
“The passion to achieve the levels of mastery that Steve and Francisco demonstrate on a daily basis cannot be taught in any school and cannot be demanded by one’s employer. It is entirely innate,” said IFF Chairman & CEO Andreas Fibig. “Our responsibility is to create the environment that lets that passion take root and flourish. I am beyond proud to honor the depth, breadth, and impact of Francisco and Steve’s contributions - ones that bring joy to so many people around the world. We congratulate them on their many achievements and look forward to many more.”
As a teenager interested in chemistry, Mr. Marano began his journey in a flavors lab in Brazil until a job opened in one for fragrances. Fascinated by perfumery, he continued his chemistry studies in high school and worked to develop his unique olfactive skills - the results of which were noticed by his manager and laid the groundwork for his future. When the invitation to train as a perfumer materialized, Mr. Marano realized that his dream was within his grasp and threw himself into learning all he could and started his career in earnest. In 1978, he joined IFF in Brazil. In the years since, his creations have found their way into the olfactive memories of countless people around the world through some of the industry’s most prestigious fine and iconic consumer brands.
“I am so honored to receive the title of Master Perfumer,” Mr. Marano said. “It is the ultimate tribute in a perfumer’s career and a genuine privilege to join my colleagues Carlos, Dominique, and Steve. Perfumery is my passion – to have this recognition for something I love is the greatest reward I could imagine.”
Mr. Nicoll’s career path began, one could say, in his blood. His Parisienne grandmother, a talented cook, taught him to smell every ingredient before adding it to a dish. His father was a perfumer who worked for several fragrance companies in England -- and came home every day smelling of his latest creation. It was while working with his father at Bourjois Chanel in London as a summer job that he first saw how perfumers fit into the intricacies of fragrance and cosmetics manufacture and his curiosity was piqued. His father set up a small lab at home and began his fragrance compounding education in parallel to his schooling. His love of fragrance grew and really took flight when he was apprenticed in Grasse, France and began his formal training. He returned to the UK to complete his training and was accepted in to the British Society of Perfumers. In 1986, he joined Bush Boake Allen (BBA), transitioning to IFF when it acquired BBA in 2000. His career has been shaped by his passion for understanding what’s most important to the consumer experience and his commitment to surpassing their expectations.
Mr. Nicoll said, “Being curious by nature, I was always fascinated by how things smell. I am fortunate to have discovered a career that allows me to continue to be curious every day. In perfumery, we have the ability to touch millions of people’s lives through the fragrances we create -- and make their lives better, happier, and more satisfying. For a perfumer, there is no greater reward.”
Nicolas Mirzayantz, IFF Group President, Fragrances, said, “Over the course of their careers with us, Steve and Francisco have consistently created outstanding fragrances in the Consumer categories. Through their passion for and dedication to their art, they touch the lives of so many and transform the everyday. As perfumers for consumer fragrances, you won’t see Francisco’s or Steve’s name in fragrance blogs or on the bottles containing their creations, but what they make becomes part of your personal olfactive tapestry. The smell of your blanket when you were a child, the aroma of your mother’s hair, or the scent that tells you you’re home – these are the irreplaceable contributions of these incredibly talented men.”
# # #
International Flavors & Fragrances Inc. (NYSE:IFF) (Euronext Paris: IFF) is a leading innovator of sensorial experiences that move the world. At the heart of our company, we are fueled by a sense of discovery, constantly asking “what if?”. That passion for exploration drives us to co-create unique products that consumers taste, smell, or feel in fine fragrances and beauty, detergents and household goods, as well as beloved foods and beverages. Our 7,300 team members globally take advantage of leading consumer insights, research and development, creative expertise, and customer intimacy to develop differentiated offerings for consumer products. Learn more at www.iff.com, Twitter , Facebook , Instagram , and LinkedIn .
Michael DeVeau, 212-708-7164
VP, Corporate Strategy, Investor Relations & Communications
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Tilaa tiedotteet sähköpostiisi
Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.
Lue lisää julkaisijalta Business Wire
American Airlines Announces Nonstop Philadelphia (PHL) to Orlando Melbourne (MLB)22.9.2018 01:13 | Tiedote
Glorious beaches by day and theme park fireworks by night just got more convenient for Philadelphia travelers. American Airlines announced today that it will begin nonstop flights to Orlando Melbourne International Airport (MLB) starting February 16, 2019. The Central Florida airport is conveniently located in the heart of the tourism region and is the closest airport to NASA rocket launches, Port Canaveral’s cruises and what critics call “some of the most beautiful beaches Florida has to offer.” The flights will depart Saturdays from Philadelphia at 8:05 a.m., arriving in Florida at 10:48 a.m. The Embraer 175 jet arrival time syncs perfectly with cruise ship noon early boarding. Melbourne Airport Express offers nonstop shuttle service to the port, and all major rental car companies are onsite. The return flight to PHL departs at 11:24 a.m. and arrives in PHL at 1:55 p.m., with enough time to connect to some of American’s largest international destinations, including recently announced
Amy Palladino Joins BCW as Executive Vice President, Managing Director, Corporate Practice21.9.2018 20:43 | Tiedote
BCW (Burson Cohn & Wolfe), a leading global communications agency, today announced that Amy Palladino has joined the agency as Executive Vice President, Managing Director in the agency’s U.S. Corporate Practice. Based in New York, Palladino will focus on senior client counsel and executive positioning for the agency’s largest corporate clients. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180921005507/en/ Amy Palladino Joins BCW (Burson Cohn & Wolfe) “Amy is a talented and highly experienced communications executive with a track record of solving clients’ complex challenges and building business through smart, integrated communications approaches,” said Chris Foster, President, North America, BCW. “Her creativity and judgement will be enormously valuable to our current and prospective clients.” Palladino has more than 20 years of experience advising global clients across numerous industries, including technology, healthcar
Heidelberg Engineering Announces the CE-Marking of ANTERION21.9.2018 19:41 | Tiedote
Heidelberg Engineering, the leader in diagnostic imaging known for the internationally-acclaimed SPECTRALIS ® retina and glaucoma platform, announces the CE-marking of ANTERION ® – an innovative platform designed to transform anterior segment diagnostics and workflow. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180921005442/en/ The new Heidelberg Engineering ANTERION® provides the most important anterior segment examinations and measurements in one modular, upgradeable platform. (Graphic: Business Wire) The new ANTERION provides the most important anterior segment examinations and measurements in one modular, upgradeable platform. It is a single, workflow-efficient solution that brings together corneal topography and tomography, anterior segment metrics, axial length measurement and IOL calculation to transform the day-to-day routine of busy practices and clinics. Heidelberg Engineering has leveraged its core OCT technolo
Florian Winterstein Becomes New CEO of Jedox21.9.2018 18:46 | Tiedote
The supervisory board of Jedox AG, a leading vendor of business intelligence and enterprise planning software, has appointed Florian Winterstein as Chief Executive Officer (CEO) effective October 2, 2018. This nomination will support Jedox’s international growth and a new development phase initiated by its latest fund raising in April 2018 with Iris Capital, eCAPITAL entrepreneurial Partners AG and Wecken & Cie. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180921005416/en/ Florian Winterstein (Photo: Business Wire) With 25 years of experience in strategy consulting and leadership in software and service organizations, Winterstein brings to the company a valuable combination of expertise in cloud solutions, business development, and value creation for customers and partners. As former Chief Strategy Officer of BravoSolution, he positioned the software-as-a-service company as trendsetting digitalization partner, extending it
Avinor to Test Autonomous Snowploughs at Oslo Airport This Winter21.9.2018 17:37 | Tiedote
Since 2010 Avinor has had a vision and a desire to automate winter maintenance. In March autonomous snow clearing was demonstrated at Fagernes Airport, and this winter Avinor is taking this a step further by testing two autonomous snowploughs at Oslo Airport. The project is one of the first globally where large machinery will operate autonomously to keep snow away from airport areas. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180921005363/en/ Avinor to Test Autonomous Snowploughs at Oslo Airport This Winter (Photo: Business Wire) “Innovation is important to Avinor. In the future, many tasks in aviation will be resolved in other ways than today. Avinor wants to test autonomy, and does of course see a potential for rationalization in the future through new solutions for winter operations and in other areas. Avinor is at the forefront of testing this technology, but it is essential that safety is ensured in all such testing
Takeda Receives Positive CHMP Opinion Recommending ALUNBRIG® (brigatinib) for the Treatment of ALK+ Non-Small Cell Lung Cancer in Patients Previously Treated with Crizotinib21.9.2018 16:30 | Tiedote
Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion, recommending the full approval of ALUNBRIG® (brigatinib) as a monotherapy for the treatment of adult patients with anaplastic lymphoma kinase-positive (ALK+) advanced non-small cell lung cancer (NSCLC) previously treated with crizotinib. ALUNBRIG is a tyrosine kinase inhibitor (TKI) designed to target and inhibit the ALK mutation in NSCLC. Approximately three to five percent of NSCLC patients globally have the ALK mutation. If the CHMP opinion is affirmed, and the European Commission approves ALUNBRIG, it will become the only ALK inhibitor available in the European Union as a one tablet per day dose that can be taken with or without food. The randomized, global Phase 2 ALTA trial was designed to investigate the efficacy and safety of ALUNBRIG in patients with locally advanced or metastatic ALK+
Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.Tutustu uutishuoneeseemme